Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families
- 1 November 1998
- journal article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 63 (5) , 1341-1351
- https://doi.org/10.1086/302099
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- A polymorphic stop codon in BRCA2Nature Genetics, 1996
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Generation of an Integrated Transcription Map of theBRCA2Region on Chromosome 13q12–q13Genomics, 1996
- Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerNature Genetics, 1996
- Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer familiesNature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Familial hypercholesterolemia in French-Canadians: Taking advantage of the presence of a “founder effect”The American Journal of Cardiology, 1993
- Cystic fibrosis mutations in French Canadians: Three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosisAmerican Journal of Medical Genetics, 1992
- Repŕoduction demographique et transmission genetique dans le Nord-Est de la province de Quebec (18e–20e siecles)European Journal of Population, 1988